vs

Side-by-side financial comparison of Abbott Laboratories (ABT) and PepsiCo (PEP). Click either name above to swap in a different company.

PepsiCo is the larger business by last-quarter revenue ($19.4B vs $11.5B, roughly 1.7× Abbott Laboratories). Abbott Laboratories runs the higher net margin — 15.5% vs 12.0%, a 3.5% gap on every dollar of revenue. On growth, PepsiCo posted the faster year-over-year revenue change (8.5% vs 4.4%). Over the past eight quarters, Abbott Laboratories's revenue compounded faster (7.2% CAGR vs -7.0%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

PepsiCo, Inc. is an American multinational food and beverage corporation headquartered in Harrison, New York, in the hamlet of Purchase. PepsiCo's business encompasses all aspects of the food and beverage market. It oversees the manufacturing, distribution, and marketing of its products. PepsiCo was formed in 1965 with the merger of the Pepsi-Cola Company and Frito-Lay, Inc., PepsiCo has since expanded from its namesake product Pepsi to an immensely diversified range of food and beverage brands.

ABT vs PEP — Head-to-Head

Bigger by revenue
PEP
PEP
1.7× larger
PEP
$19.4B
$11.5B
ABT
Growing faster (revenue YoY)
PEP
PEP
+4.1% gap
PEP
8.5%
4.4%
ABT
Higher net margin
ABT
ABT
3.5% more per $
ABT
15.5%
12.0%
PEP
Faster 2-yr revenue CAGR
ABT
ABT
Annualised
ABT
7.2%
-7.0%
PEP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ABT
ABT
PEP
PEP
Revenue
$11.5B
$19.4B
Net Profit
$1.8B
$2.3B
Gross Margin
57.0%
55.2%
Operating Margin
19.6%
16.5%
Net Margin
15.5%
12.0%
Revenue YoY
4.4%
8.5%
Net Profit YoY
-80.8%
EPS (diluted)
$1.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABT
ABT
PEP
PEP
Q1 26
$19.4B
Q4 25
$11.5B
$29.3B
Q3 25
$11.4B
$23.9B
Q2 25
$11.1B
$22.7B
Q1 25
$10.4B
$17.9B
Q4 24
$11.0B
$27.8B
Q3 24
$10.6B
$23.3B
Q2 24
$10.4B
$22.5B
Net Profit
ABT
ABT
PEP
PEP
Q1 26
$2.3B
Q4 25
$1.8B
$2.5B
Q3 25
$1.6B
$2.6B
Q2 25
$1.8B
$1.3B
Q1 25
$1.3B
$1.8B
Q4 24
$9.2B
$1.5B
Q3 24
$1.6B
$2.9B
Q2 24
$1.3B
$3.1B
Gross Margin
ABT
ABT
PEP
PEP
Q1 26
55.2%
Q4 25
57.0%
53.2%
Q3 25
55.4%
53.6%
Q2 25
56.4%
54.7%
Q1 25
56.9%
55.8%
Q4 24
55.0%
52.6%
Q3 24
55.8%
55.4%
Q2 24
55.6%
55.9%
Operating Margin
ABT
ABT
PEP
PEP
Q1 26
16.5%
Q4 25
19.6%
12.1%
Q3 25
18.1%
14.9%
Q2 25
18.4%
7.9%
Q1 25
16.3%
14.4%
Q4 24
17.4%
8.1%
Q3 24
17.5%
16.6%
Q2 24
16.1%
18.0%
Net Margin
ABT
ABT
PEP
PEP
Q1 26
12.0%
Q4 25
15.5%
8.7%
Q3 25
14.5%
10.9%
Q2 25
16.0%
5.6%
Q1 25
12.8%
10.2%
Q4 24
84.1%
5.5%
Q3 24
15.5%
12.6%
Q2 24
12.5%
13.7%
EPS (diluted)
ABT
ABT
PEP
PEP
Q1 26
Q4 25
$1.01
$1.85
Q3 25
$0.94
$1.90
Q2 25
$1.01
$0.92
Q1 25
$0.76
$1.33
Q4 24
$5.26
$1.11
Q3 24
$0.94
$2.13
Q2 24
$0.74
$2.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABT
ABT
PEP
PEP
Cash + ST InvestmentsLiquidity on hand
$8.9B
$10.8B
Total DebtLower is stronger
$12.9B
Stockholders' EquityBook value
$52.1B
$21.5B
Total Assets
$86.7B
$110.6B
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABT
ABT
PEP
PEP
Q1 26
$10.8B
Q4 25
$8.9B
$9.5B
Q3 25
$7.7B
$8.7B
Q2 25
$7.3B
$8.0B
Q1 25
$6.8B
$8.6B
Q4 24
$8.0B
$9.3B
Q3 24
$7.8B
$8.1B
Q2 24
$7.2B
$6.7B
Total Debt
ABT
ABT
PEP
PEP
Q1 26
Q4 25
$12.9B
$42.3B
Q3 25
$44.1B
Q2 25
$39.3B
Q1 25
$39.4B
Q4 24
$14.1B
$37.2B
Q3 24
$38.5B
Q2 24
$36.6B
Stockholders' Equity
ABT
ABT
PEP
PEP
Q1 26
$21.5B
Q4 25
$52.1B
$20.4B
Q3 25
$51.0B
$19.4B
Q2 25
$50.6B
$18.4B
Q1 25
$48.8B
$18.4B
Q4 24
$47.7B
$18.0B
Q3 24
$39.8B
$19.5B
Q2 24
$39.3B
$19.4B
Total Assets
ABT
ABT
PEP
PEP
Q1 26
$110.6B
Q4 25
$86.7B
$107.4B
Q3 25
$84.2B
$106.6B
Q2 25
$84.0B
$105.3B
Q1 25
$81.4B
$101.7B
Q4 24
$81.4B
$99.5B
Q3 24
$74.4B
$100.5B
Q2 24
$73.0B
$99.5B
Debt / Equity
ABT
ABT
PEP
PEP
Q1 26
Q4 25
0.25×
2.07×
Q3 25
2.28×
Q2 25
2.14×
Q1 25
2.14×
Q4 24
0.30×
2.06×
Q3 24
1.98×
Q2 24
1.88×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABT
ABT
PEP
PEP
Operating Cash FlowLast quarter
$3.3B
Free Cash FlowOCF − Capex
$2.6B
FCF MarginFCF / Revenue
22.9%
Capex IntensityCapex / Revenue
6.0%
Cash ConversionOCF / Net Profit
1.87×
TTM Free Cash FlowTrailing 4 quarters
$7.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABT
ABT
PEP
PEP
Q1 26
Q4 25
$3.3B
$6.6B
Q3 25
$2.8B
$4.5B
Q2 25
$2.0B
$2.0B
Q1 25
$1.4B
$-973.0M
Q4 24
$2.9B
$6.3B
Q3 24
$2.7B
$4.9B
Q2 24
$2.0B
$2.4B
Free Cash Flow
ABT
ABT
PEP
PEP
Q1 26
Q4 25
$2.6B
$4.7B
Q3 25
$2.3B
$3.5B
Q2 25
$1.5B
$1.1B
Q1 25
$933.0M
$-1.6B
Q4 24
$2.1B
$3.8B
Q3 24
$2.1B
$3.8B
Q2 24
$1.4B
$1.3B
FCF Margin
ABT
ABT
PEP
PEP
Q1 26
Q4 25
22.9%
16.0%
Q3 25
20.2%
14.5%
Q2 25
13.9%
4.7%
Q1 25
9.0%
-8.8%
Q4 24
19.6%
13.7%
Q3 24
20.2%
16.1%
Q2 24
13.8%
5.6%
Capex Intensity
ABT
ABT
PEP
PEP
Q1 26
Q4 25
6.0%
6.5%
Q3 25
4.4%
4.1%
Q2 25
4.5%
4.0%
Q1 25
4.7%
3.4%
Q4 24
6.6%
8.9%
Q3 24
5.2%
4.9%
Q2 24
5.1%
4.8%
Cash Conversion
ABT
ABT
PEP
PEP
Q1 26
Q4 25
1.87×
2.61×
Q3 25
1.70×
1.72×
Q2 25
1.15×
1.56×
Q1 25
1.07×
-0.53×
Q4 24
0.31×
4.13×
Q3 24
1.64×
1.67×
Q2 24
1.51×
0.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons